Archive - Latest News Search Engine - Global and Local Breaking News

Two-Phase Study Leads to Monteloeder's Newest Nootropic for Cognitive Performance

Two-Phase Study Leads to Monteloeder's Newest Nootropic for Cognitive Performance

AKTIS ONCOLOGY TO PARTICIPATE IN THE 45th ANNUAL TD COWEN HEALTH CARE CONFERENCE

AKTIS ONCOLOGY TO PARTICIPATE IN THE 45th ANNUAL TD COWEN HEALTH CARE CONFERENCE

Setting a New Standard for Intelligent Factories: Angel Yeast Drives Eco-Collaboration and Human-Machine Coexistence in Smart Production

Setting a New Standard for Intelligent Factories: Angel Yeast Drives Eco-Collaboration and Human-Machine Coexistence in Smart Production

Ultima Genomics expands global access to high-quality, low-cost DNA sequencing on the UG 100™ sequencing platform through partnerships with multiple premier genomic services providers

Ultima Genomics expands global access to high-quality, low-cost DNA sequencing on the UG 100™ sequencing platform through partnerships with multiple premier genomic services providers

Your briefing

Two-Phase Study Leads to Monteloeder's Newest Nootropic for Cognitive Performance

Mindrevive™, composed of extracts of sage and Japanese pagoda tree, found to help enhance mental resilience in older adults MADRID, Feb. 25, 2025 /PRN...

Two-Phase Study Leads to Monteloeder's Newest Nootropic for Cognitive Performance

AKTIS ONCOLOGY TO PARTICIPATE IN THE 45th ANNUAL TD COWEN HEALTH CARE CONFERENCE

BOSTON, Feb. 25, 2025 /PRNewswire/ -- Aktis Oncology, an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuti...

AKTIS ONCOLOGY TO PARTICIPATE IN THE 45th ANNUAL TD COWEN HEALTH CARE CONFERENCE

Setting a New Standard for Intelligent Factories: Angel Yeast Drives Eco-Collaboration and Human-Machine Coexistence in Smart Production

YICHANG, China, Feb. 25, 2025 /PRNewswire/ -- Against a backdrop of geopolitical tensions and technological advancements reshaping the world, the 2025...

Setting a New Standard for Intelligent Factories: Angel Yeast Drives Eco-Collaboration and Human-Machine Coexistence in Smart Production

Ultima Genomics expands global access to high-quality, low-cost DNA sequencing on the UG 100™ sequencing platform through partnerships with multiple p...

FREMONT, Calif., Feb. 25, 2025 /PRNewswire/ -- Ultima Genomics, Inc., developer of the UG100™ next-generation sequencing (NGS) platform, today announc...

Ultima Genomics expands global access to high-quality, low-cost DNA sequencing on the UG 100™ sequencing platform through partnerships with multiple premier genomic services providers